The study review represents scientific documentaries demonstrating the effectiveness of camel milk as a superfood for diabetes.

With approximately 2.91 million tons of milk produced annually, camels rank fifth among dairy animals globally, accounting for 0.36% of global milk production.

Generally speaking, diabetes is characterized by chronic hyperglycemia in the blood caused by an insufficient amount of insulin secreted or a malfunctioning insulin receptor.

Diabetes type 1 has many complications and affects many of the world’s population. Three-quarters of the world’s population cannot take allopathic medications and rely instead on natural products derived from animals and plants.

The focus has recently been on natural foods and traditional medicine. For example, type 1 diabetes is usually treated with insulin, which has to be resistant to enzymatic degradation and easily absorbed. However, insulin coagulates in the stomach and loses its effects on lowering blood sugar, and it is also expensive.

It is common for African, Asian, and Middle Eastern people to use camel milk as an alternative to drugs to treat diabetes. However, research shows insulin is the primary cure for type 1 diabetes.

As well as enhancing kidney and liver function and improving lipid metabolism associated with type 1 diabetes, camel’s milk also plays an essential role in maintaining pancreatic beta cells’ function.

The presence of insulin-like protein in camel milk (about 52 units/liter) may contribute to its anti-diabetic activity. Therefore, people can use it to treat type 1 and type 2 diabetes as well as gestational diabetes with similar effectiveness to insulin.

In patients with type 1 diabetes, camel milk may produce about 60% of the required insulin and reduce blood glucose levels and requirements by 30 – 35%. In addition, raw camel milk has immune-modulatory effects on pancreatic beta-cells, increases insulin secretion, reduces required insulin and insulin resistance, and improves glycemic control in type 1 diabetes patients.

A study retrieved 73 articles from the initial search; after screening abstracts and full texts, 22 articles were included, of which 11 were animal studies and 11 were clinical trials, with eight focusing on type 1 diabetes and the other three on type 2 diabetes.

Except for one animal study, all diabetic parameters, including blood glucose, insulin resistance, glycated hemoglobin, and lipid profile, were significantly reduced. In addition, most clinical trials recommended 500 mL of camel milk per day to patients with diabetes, which improved diabetes markers even after three months.

In diabetes 1 and 2 patients, lactoferrin from camel milk reduces insulin doses and modulates the immune system of the pancreas beta cells. In most clinical trials, camel milk was shown to be beneficial in treating diabetes mellitus and reducing risk factors associated with diabetes mellitus. These risk factors included liver and kidney failures and cardiovascular challenges.

In human subjects and animal models, camel milk has improved long-term glycemic control and is safe to consume. However, more scientific studies are necessary to confirm this claim. 

Written by